Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2316676
Max Phase: Preclinical
Molecular Formula: C45H60N2O12S
Molecular Weight: 853.04
Molecule Type: Small molecule
Associated Items:
ID: ALA2316676
Max Phase: Preclinical
Molecular Formula: C45H60N2O12S
Molecular Weight: 853.04
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)/C(=N\OCC#Cc2ccc(C(=O)c3ccccc3)s2)[C@H](C)[C@H]2OC(=O)O[C@@]21C
Standard InChI: InChI=1S/C45H60N2O12S/c1-12-34-45(8)40(58-43(52)59-45)27(4)35(46-54-22-16-19-31-20-21-33(60-31)37(49)30-17-14-13-15-18-30)25(2)24-44(7,53-11)39(28(5)36(48)29(6)41(51)56-34)57-42-38(50)32(47(9)10)23-26(3)55-42/h13-15,17-18,20-21,25-29,32,34,38-40,42,50H,12,22-24H2,1-11H3/b46-35+/t25-,26-,27+,28+,29-,32+,34-,38-,39-,40-,42+,44-,45-/m1/s1
Standard InChI Key: ZYNSMZNREXLJGY-JZIRDJOXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 853.04 | Molecular Weight (Monoisotopic): 852.3867 | AlogP: 6.05 | #Rotatable Bonds: 9 |
Polar Surface Area: 168.72 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.93 | CX Basic pKa: 8.27 | CX LogP: 8.24 | CX LogD: 7.63 |
Aromatic Rings: 2 | Heavy Atoms: 60 | QED Weighted: 0.08 | Np Likeness Score: 1.00 |
1. Liang JH, An K, Lv W, Cushman M, Wang H, Xu YC.. (2013) Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides., 59 [PMID:23202851] [10.1016/j.ejmech.2012.10.054] |
Source(1):